This grant is for supporting pilot projects on understudied proteins, specifically non-olfactory G Protein-Coupled Receptors, protein kinases, and ion channels, identified by the Illuminating the Druggable Genome (IDG) Program. Its purpose is to generate new data and tools, extending characterization beyond IDG Centers’ scope. Projects should validate and demonstrate the utility of IDG-generated reagents and data, elucidating protein function in human disease. This initiative aims to enhance the IDG Program by showcasing resource quality, increasing scientific awareness of IDG-generated resources, and deepening characterization of IDG-eligible proteins.
Opportunity ID: 339550
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-RM-22-024 |
Funding Opportunity Title: | Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.310 — Trans-NIH Research Support |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 15, 2022 |
Last Updated Date: | Apr 15, 2022 |
Original Closing Date for Applications: | Jul 15, 2022 |
Current Closing Date for Applications: | Jul 15, 2022 |
Archive Date: | Aug 20, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public and State controlled institutions of higher education Special district governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments Small businesses State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The goal of this funding opportunity announcement (FOA) for the Common Fund Program “Illuminating the Druggable Genome” (IDG; https://commonfund.nih.gov/idg/index) is to solicit applications for pilot projects on IDG-eligible understudied proteins (non-olfactory GPCRs, protein kinases, and ion channels) in order to study them beyond what the IDGs Centers can accomplish and to validate and demonstrate the utility of IDG-generated reagents, data, and approaches.Awards will support the generation of additional data and tools around understudied protein(s) identified by the IDG Program to elucidate the function of these proteins in the context of human disease. Data collected and tools generated by these projects will enhance the overall goals of the IDG Program by demonstrating the quality and utility of IDG-generated data and reagents to the scientific community, increasing awareness of the IDG Program through use of IDG-generated resources, and/or extending the characterization of IDG-eligible proteins. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-024.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00273393 | Jun 15, 2022 | Jul 15, 2022 | View |
Package 1
Mandatory forms
339550 RR_SF424_5_0-5.0.pdf
339550 PHS398_CoverPageSupplement_5_0-5.0.pdf
339550 RR_OtherProjectInfo_1_4-1.4.pdf
339550 PerformanceSite_4_0-4.0.pdf
339550 RR_KeyPersonExpanded_4_0-4.0.pdf
339550 PHS398_ResearchPlan_4_0-4.0.pdf
339550 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
339550 RR_Budget_3_0-3.0.pdf
339550 RR_SubawardBudget30_3_0-3.0.pdf
339550 PHS398_ModularBudget_1_2-1.2.pdf
339550 PHS_AssignmentRequestForm_3_0-3.0.pdf